intelligent medicine
元码智药
intelligent medicine
Biotech/Healthcare
Yuanma Intelligent Medicine has completed several tens of millions of yuan in Pre-A financing. The funds will be used for clinical filings for its pipelines and the development of an AI drug discovery and development engine, strengthening its competitiveness in immunotherapy.
Latest round: Pre Series A (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-07-22
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.